Jeroen Overman

Non-Clinical Hepatic Safety Lead

Basel, Basel, Switzerland

About

Experience

  • Principal Scientist | Non-clinical Liver Science Lead at Roche
    May 2025 - Present · 1 yr 2 mos

  • Senior Research Scientist at AstraZeneca
    Aug 2020 - May 2024 · 3 yrs 10 mos

  • Scientist at Charles River Laboratories
    Jun 2018 - Aug 2020 · 2 yrs 3 mos

  • PhD Candidate at The University of Queensland
    Oct 2012 - Jun 2018 · 5 yrs 9 mos

    Thesis title: "Pharmacological modulation of SOX18 transcription factor activity in development and disease". The main goal of my doctorate was to validate novel drug targets and screen for small molecule inhibitors of a transcription factor in the context of cardio-vascular development and tumour metastasis. I developed a complete pipeline of in vitro assays and in vivo model systems to obtain novel lead compounds; integrating HTS, high content imaging, reporter gene assay, toxicity readouts, various -omics tools, mouse disease models and ADME.